Halmox CV 625 Tablets: A Powerful Combination for Respiratory Infections

Halmox CV 625 Tablets are a synergistic combination of Amoxycillin and Clavulanic Acid, effective against a wide range of bacteria commonly causing respiratory infections. This double-action formula targets both the bacterial cause of these illnesses and the development of antibiotic resistance.

Amoxicillin (500mg): A powerful broad-spectrum antibiotic that combats various gram-positive and some gram-negative bacteria.
Clavulanic Acid (125mg): A beta-lactamase inhibitor, which prevents bacterial enzymes from breaking down the Amoxycillin's effectiveness.

Halmox CV 625 Tablets are formulated for oral administration in adults and children 8 years of age and above. This combination provides effective relief for conditions like pneumonia, bronchitis, sinusitis, and tonsillitis. Always follow your physician's dosage instructions and consult a healthcare professional if any adverse reactions occur.

Key Benefits:
* Effective treatment for respiratory infections.
* Combats bacterial resistance by using amoxicillin and clavulanic acid in synergy.
* High bioavailability for optimal treatment efficacy.

Please note: This product should only be taken as directed by your healthcare professional. This information is intended for general knowledge and does not constitute medical advice.